Advertisement
Advertisement

TGTX

TGTX logo

TG Therapeutics, Inc.

55.16
USD
Sponsored
+0.22
+0.39%
Jul 01, 11:54 UTC -4
Open

TGTX Earnings Reports

Positive Surprise Ratio

TGTX beat 12 of 42 last estimates.

29%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$233.07M
/
$0.33
Implied change from Q1 26 (Revenue/ EPS)
+13.74%
/
+83.33%
Implied change from Q2 25 (Revenue/ EPS)
+65.12%
/
+94.12%

TG Therapeutics, Inc. earnings per share and revenue

On May 06, 2026, TGTX reported earnings of 0.18 USD per share (EPS) for Q1 26, missing the estimate of 0.30 USD, resulting in a -40.10% surprise. Revenue reached 204.92 million, compared to an expected 200.75 million, with a 2.08% difference. The market reacted with a +16.26% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.33 USD, with revenue projected to reach 233.07 million USD, implying an increase of 83.33% EPS, and increase of 13.74% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, TG Therapeutics, Inc. reported EPS of $0.18, missing estimates by -40.1%, and revenue of $204.92M, 2.08% above expectations.
The stock price moved up 16.26%, changed from $36.10 before the earnings release to $41.97 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on -- analysts, TG Therapeutics, Inc. is expected to report EPS of $0.33 and revenue of $233.07M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement